Abstract
Medulloblastoma (MB) is extremely rare in adults (1% of CNS tumors). Comparative studies show important biological differences between adult and pediatric patients with implications in clinical behaviour and patient outcomes. Although MB is potentially curable with a multidisciplinary approach comprising a combination of maximal safe resection, craniospinal irradiation (CSI), and chemotherapy (CT), the lack of specific studies in the adult subpopulation forces oncologist to adapt treatment regimens.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
